Diagnostic accuracy of adenosine versus dobutamine stress perfusion cardiovascular magnetic resonance to detect severe coronary artery disease in patients with reduced left ventricular ejection fraction.Background: Stress cardiovascular magnetic resonance (CMR) is a common non-invasive modality used for the diagnosis of coronary artery disease (CAD). However, its accuracy for diagnosing CAD in patients with moderate to severe left ventricular systolic dysfunction (M-S LVSD) is unclear. Although adenosine is the most commonly used agent in stress CMR, haemodynamic responses to adenosine may be diminished in M-S LVSD, so an alternative strategy utilising inotropic stress may provide superior diagnostic performance. We hypothesised that dobuta...
Objective: To evaluate the reproducibility of first-pass contrast-enhanced cardiac MR (CMR) myocardi...
Objective: To evaluate the reproducibility of first-pass contrast-enhanced cardiac MR (CMR) myocardi...
BACKGROUND: GadaCAD2 was 1 of 2 international, multicenter, prospective, Phase 3 clinical trials tha...
Aim: To determine the factors associated with an inadequate response to adenosine infusion during ca...
OBJECTIVES : We wanted to assess the burden of coronary artery disease (CAD) in patients with suspec...
BACKGROUND: Late gadolinium enhanced cardiovascular magnetic resonance (LGE-CMR) has excellent speci...
BACKGROUND: Late gadolinium enhanced cardiovascular magnetic resonance (LGE-CMR) has excellent speci...
Objectives: This study aimed to compare dobutamine stress cardiac magnetic resonance (DSCMR) with d...
Objectives: This study aimed to compare dobutamine stress cardiac magnetic resonance (DSCMR) with d...
Objectives: The purpose of this study was to investigate whether a direct relation can be demonstrat...
Objectives: The purpose of this study was to investigate whether a direct relation can be demonstrat...
We sought to assess the tolerance and safety of adenosine-stress cardiovascular magnetic resonance (...
Objectives: The purpose of this study was to investigate whether a direct relation can be demonstrat...
ObjectivesThis study was designed to determine the diagnostic value of adenosine cardiac magnetic re...
Abstract Purpose First-pass perfusion cardiovascular magnetic resonance (CMR) is increasingly being ...
Objective: To evaluate the reproducibility of first-pass contrast-enhanced cardiac MR (CMR) myocardi...
Objective: To evaluate the reproducibility of first-pass contrast-enhanced cardiac MR (CMR) myocardi...
BACKGROUND: GadaCAD2 was 1 of 2 international, multicenter, prospective, Phase 3 clinical trials tha...
Aim: To determine the factors associated with an inadequate response to adenosine infusion during ca...
OBJECTIVES : We wanted to assess the burden of coronary artery disease (CAD) in patients with suspec...
BACKGROUND: Late gadolinium enhanced cardiovascular magnetic resonance (LGE-CMR) has excellent speci...
BACKGROUND: Late gadolinium enhanced cardiovascular magnetic resonance (LGE-CMR) has excellent speci...
Objectives: This study aimed to compare dobutamine stress cardiac magnetic resonance (DSCMR) with d...
Objectives: This study aimed to compare dobutamine stress cardiac magnetic resonance (DSCMR) with d...
Objectives: The purpose of this study was to investigate whether a direct relation can be demonstrat...
Objectives: The purpose of this study was to investigate whether a direct relation can be demonstrat...
We sought to assess the tolerance and safety of adenosine-stress cardiovascular magnetic resonance (...
Objectives: The purpose of this study was to investigate whether a direct relation can be demonstrat...
ObjectivesThis study was designed to determine the diagnostic value of adenosine cardiac magnetic re...
Abstract Purpose First-pass perfusion cardiovascular magnetic resonance (CMR) is increasingly being ...
Objective: To evaluate the reproducibility of first-pass contrast-enhanced cardiac MR (CMR) myocardi...
Objective: To evaluate the reproducibility of first-pass contrast-enhanced cardiac MR (CMR) myocardi...
BACKGROUND: GadaCAD2 was 1 of 2 international, multicenter, prospective, Phase 3 clinical trials tha...